Genotype C/C 13910 of the Lactase Gene  as a Risk Factor for the Formation  of Insulin-Resistant Obesity in Children by Abaturov, Aleksandr & Nikulina, Anna
150 original article
Genotype C/C 13910 of the Lactase Gene  
as a Risk Factor for the Formation  
of Insulin-Resistant Obesity in Children
Aleksandr Abaturov, Anna Nikulina*
ABSTRACT
Introduction: To reduce the risk of insulin resistance in obesity in children with lactase gene genotypes, we studied the factors that 
stimulate the chronic inflammatory process. Material and methods: 109 children 6–18 years of age were investigated. The main group  
(n = 56) was presented by children with signs of insulin-resistant obesity according to the criteria of the European Society of Endocrinology 
and the Pediatric Endocrine Society. The control group (n = 53) included obese children without insulin resistance. A comprehensive clinical 
examination, food diary analysis, genotyping of the lactase gene by means of the polymerase chain reaction, the Immunochemical Test 
Method with Electrochemiluminescent Detection of basal insulinemia, Hydrogen breath test with lactose load, sequential analysis, ROC 
analysis were carried out. Results: Clinical manifestations of lactose maldigestion in a child increased the risk of possible insulin resistance 
(prognostic coefficient (PC +2.6), as well as the presence of the lactase C/C 13910 gene genotype (PC +5.8) did. The genotype C/T 13910 in 
children had a protective effect on the risk of obesity (PC −2.9). The lowest risk of insulin-resistant obesity in observed among children with 
the genotype T/T 13910 (PC −12). Conclusion: The presence of the C/C 13910 genotype of the lactase gene is the main factor formation of 
insulin resistance in children’s obesity. 
What is known? The genotype C/C 13910 of the lactase gene as a risk factor for the chronic inflammatory process in the body. 
What is New? Genotype C/C 13910 of the lactase gene as a risk factor for insulin-resistant obesity in children.
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INTRODUCTION
The discrepancy between the amount of lactose being 
consumed in the diet and the ability to secrete the lactase 
enzyme underlies the persistence of the chronic inflam-
matory process and the formation of obesity and insulin 
resistance. The degree of transcription of the lactase gene 
(LCT), OMIM 603202NG_008104 depends on the charac-
teristics of the MCM6 (minichromosome maintenance com-
plex 6) enhancer. Single nucleotide polymorphisms (SNP) 
of the cis-regulatory element MCM6, which are character-
ized by the replacement of cytosine (C) with thymine (T) 
in the 13th MCM6 intron at position 13910 for 14 kb from 
the LCT locus, cause a high penetrance of the lactase gene. 
The average level of lactase activity in European children 
with the genotype C/C 13910 is 6.5 U/g (adult-type lactase 
deficiency, LD), while the activity of lactase with the C/T 
genotype is 29.9 U/g (heterozygous lactase persistence), 
and with genotype T/T 50 U/g (homozygous lactase per-
sistence) (1).
Our study focuses on solving one of the global medical 
and social problems in pediatrics caused by a significant 
spread of childhood obesity in an urbanized society (2) 
with LCT genotypes, studying the factors that cause chron-
ic inflammation.
The aim of this work was to study the factors that induce 
insulin resistance within obesity in children caused by 
a genetically determined impairment of lactose digestion.
MATERIALS AND METHODS
To build a mathematical model for predicting the proba-
bility of insulin-resistant obesity in the early diagnostic 
stage, out of 109 children aged 6–18 years, two groups 
were identified. The main group (n = 56) was presented 
by children with insulin-resistant obesity according to the 
recommendations of The European Society of Endocrinol-
ogy and the Pediatric Endocrine Society (3). The control 
group (n = 53) was formed by children with no signs of 
insulin-resistant obesity.
Genotyping was carried out at the polymorphic locus 
of the LCT gene by real-time polymerase chain reaction 
(RT-PCR) in 109 obese children from 6 to 18 years of age 
in a certified laboratory Synevo. The material for the study 
was venous blood. 
Genotyping for signs of allelic polymorphism of the 
c.-13910 T>C LCT gene was started on the extraction of 
genomic DNA from peripheral blood leukocytes using the 
AmliPrime DNA-Sorb B reagent kit according to the man-
ufacturer’s instructions (CFX96 (BioRad), USA). In order to 
recognize alleles in the studied samples, the following clas-
sification was used: Allele 1 – allele, the indicated position of 
the C → T replacement; Allele 2 is the allele indicated after 
the C → T replacement position. Amplifications were per-
formed on a CFX 96 amplifier (BioRad, USA) with the addi-
tion of up to 20 ng of isolated reaction mixture containing: 
20 μg of SNP Genotyping Assay Mix (Applied Biosystems, 
USA) and 2 ng of Universal PCR Master Mix buffer solution 
(Applied Biosystems, USA). In the process of amplification, 
a simultaneous hybridization – fluorescence detection was 
performed on samples using fluorescent probes on a DNA 
analyzer according to the Assays-onDemand protocols for 
SNP genotyping (No 4331183, Applied Biosystems, USA). 
Thus, three types of amplification products were deter-
mined: determination of the fluorescent signal only from 
the VIC dye – homozygote for gene 1 (genotype C/C 13910), 
simultaneously fluorescent signals from the dye VIC and 
FAM – heterozygote for genome 2 (genotype C/T 13910), 
fluorescent signal only from FAM dye – homozygote for ge-
nome 2 (T/T 13910 genotype).
To detect basal insulinemia and glycaemia in venous 
blood, the Immunochemical Test Method with Electro-
chemiluminescent Detection (ECLIA) in the Synevo labo-
ratory was used. We calculated the level of sensitivity of 
peripheral tissues to insulin, the insulin resistance index 
HOMA (Homeostasis Model Assesment), using the formu-
la (1):
HOMA-IR = (fasting glycaemia (mmol/L) × fasting in-
sulin (μAU/L)) / 22.5 (1).
HOMA-IR is one of the clinical criteria for insulin re-
sistance. An increase in insulin resistance was observed 
with HOMA-IR> 95th percentile, respectively, with per-
centile curves recommended by the IDEFICS Consortium 
for the European population according to the age and gen-
der of the child (4).
Hydrogen breath test with lactose load, 25 g (HBTLL). 
The concentration of hydrogen in exhaled air was deter-
mined by the Gastro + Gastrolyser gas analyzer of the Brit-
ish company Bedfont® Scientific Ltd in parts per million 
(ppm) with an accuracy of ± 1 ppm. Automatic data analy-
sis was performed using GastroCHART software (Bedfont® 
Scientific Ltd Station Road, Harrietsham, Maidstone, Kent, 
ME17 1JA, UK). Duration HBTLL was 3 hours at intervals of 
30 minutes. A test was considered positive when the level 
of hydrogen in exhaled air increased after 60 minutes, by 
more than 20 ppm compared to the basal level and clinical 
symptoms of lactase intolerance (abdominal pain, flatu-
lence, and diarrhea) appeared on a visual-analogue scale 
for the next eight hours observations (5).
In determining the gradation of quantitative variables, 
generally accepted ideas about the risk factors of obesity 
complicated with insulin resistance were used (3, 6–8).
The algorithm for constructing a prognostic model in-
cluded the following steps (9):
– Calculation of weighted prognostic (diagnostic) coeffi-
cients (PC) for each factor using the sequential analysis 
of Wald and determining the Kullback’s informative co-
efficient (I) for each factor; 
– Selection of factors with sufficient informativeness 
(I ≥ 0.5) and the compilation of a prognostic model that 
included only those signs that had sufficient informa-
tiveness;
– Calculation of the total score of prognostic factors 
(ΣPC) for each observation in the study groups;
– Definition of logistic regression parameters by total 
points and calculation of the theoretical probability of 
insulin-resistant obesity for each observation;
– Development of a scale for assessing the probability of 
insulin-resistant obesity by the total score;
– Evaluation of the developed prognostic model with the 
use of ROC analysis and other statistical criteria.
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To predict the disease, we carried out a sequential pro-
cedure for summing up diagnostic (prognostic) factors. 
Prognostic factors corresponded to the signs identified 
in the patient before reaching the diagnostic threshold. 
The choice of diagnostic thresholds (the sum of diagnostic 
factors), allowing to predict the occurrence of pathology, 
was carried out using errors of type 1 and type 2, and to 
achieve an accurate prediction probability of 95% focused 
on the range: ΣPC ≥ 13.0 – pathology is predicted, or ΣPC ≤ 
−13.0 – the absence of pathology is predicted. According-
ly, in order to achieve a 99% probability of an error-free 
forecast, we focused on the range of ΣPС ≥ 20.0 and ΣPС ≤ 
−20.0, respectively. If  the amount was in the range be-
tween certain diagnostic thresholds, we concluded that 
there is not enough information to make a decision about 
the indicated error levels. The obtained sum of points of 
prognostic factors (ΣPC) for each observation was calcu-
lated taking into account the corresponding weight quali-
fication (Fig. 1) and on its basis, the parameters of logistic 
regression were determined by formulas (2), (3):
P = exp (z) / (1 + exp (z)), z = b0 + b1 × (ΣPС) (2), where 
P is the theoretical probability of insulin-resistant obesity 
in children; ΣPC is the sum of points for a specific patient; 
b0 and b1 are regression coefficients.
The resulting regression equation:
 P = exp (1.0976614708555+ (0.11163272142568) × ΣPС) 
/ (1 + exp (1.0976614708555+ (+0.11163272142568) × 
ΣPC)) (3).
Building a regression equation with the determination 
of threshold values of the total score allowed us to devel-
op a classification by ΣPC to determine children with low, 
medium and high risk of developing insulin-resistant obe-
sity. The criterion for assigning a child to a particular risk 
group was the value of the calculated probability P, which 
ranges from 0 to 1, and a level greater than 0.5 (or 50%) 
indicates an increased risk and corresponds to ΣPC more 
than 10 points.
Statistical processing of research results included cal-
culation of Spearman’s rank correlation coefficient, Wald 
sequential analysis with the use of the STATISTICA soft-
ware package (version 6.1) of the AGAR 909E415822FA se-
rial number, adapted for biomedical research. ROC analy-
sis and construction of ROC curves was carried out in the 
software package of the trial version of Medical Software 
Software 17.4 (MedCalc Software, Ostend, Belgium, https://
www.medcalc.org, 2017).
RESULTS
In 56 children with insulin-resistant obesity (main 
group) and 53 children without insulin-resistant obesity 
(control group) aged 6–18, the following lactase gene gen-
otypes were determined. The main group was dominated 
by the C/C 13910 genotype – in 51.76% of patients (29/56), 
the C/T 13910 genotype was found in 35.29% of the pa-
tients (20/56), the T/T 13910 genotype – only in 12.94% of 
patients (7/56). In children of the control group, the C/C 
13910 genotype was found in 25% (13/53), the C/T 13910 
genotype in 54.17% (29/53), the T/T 13910 genotype in 
20.83% (11/53). By gender, in the main clinical group, boys 
predominated (60.4% versus 39.6%). Then, as among the 
children of the control group, girls prevailed, the number 
of which was 58.33% versus 41.66% of boys, but the sta-
tistical significance of these differences was not observed 
(p > 0.05).
Risk factors for the formation of insulin resistance cor-
relate most strongly among themselves in the group of ex-
amined children with the LCT C/C 13910 genotype. In this 
group of examined patients, the presence of insulin-re-
sistant obesity correlates with the level of systolic blood 
pressure (SBP) – ρ = 0.48 (p < 0.05), the ratio of the waist 
circumference to the hips (WC/HC) is ρ = 0.45 (p < 0.05). 
HOMA-IR index before treatment is ρ = 0.54 (p < 0.05), 
which in turn associated with an indicator of a hydrogen 
respiratory test with lactose load (HBTLL) > 20 ppm (ρ = 
0.41; p < 0.05).
Analysis of the clinical and anamnestic characteristics 
of children who had various forms of obesity allowed us to 
separate the risk factors for insulin-resistant obesity at an 
early diagnostic stage.
To determine the specific weight of each of the 243 ana-
lyzed clinical and biological factors, the prognostic factor 
(PC) was calculated. When comparing the age structure of 
children with insulin-resistant obesity and metabolical-
ly favorable obesity, we found that the minimum risk of 
insulin resistance is possible at the age from 4 to 8 years 
(PC −4.5), and the maximum risk – at the age from 12 to 18 
years (PC +2.7). Gender features did not have a statistically 
significant effect on the risk of the formation of metaboli-
cally unfavorable obesity.
The risk of insulin resistance increases the complicat-
ed antenatal period (PC +3.6); hereditary burden of met-
abolic syndrome (PC +2,9); the presence of overweight 
in early childhood (PC +3); the presence of pneumonia at 
puberty (PC +7); tallness or physical development at the 
time of the study, above the 67.34th percentile (PC +1.8); 
violation of puberty initiation (PC +5,8); acne vulgaris (PC 
+6). Studying the eating behavior of children with various 
forms of obesity based on food diaries has shown that the 
average duration of food increases the risk of insulin-re-
sistant obesity to less than 10 minutes (PC +4.5). Then, as 
a quiet meal during 20 minutes reduces the risk of insulin 
resistance (PC −6.7). Significantly increases the probabil-
ity of insulin resistance and nutritional composition. For 
example, daily consumption of red meat, sausages, pota-
toes, rice, margarine, sugary drinks increases the risk of 
the formation of insulin-resistant obesity (PC +6.4). On the 
contrary, daily consumption of fresh vegetables and fruits 
in the form of 2–3 portions (children’s palms) reduces the 
risk of insulin resistance (PC −5.5). Lifestyle modification 
requires reducing non-academic use of a computer/TV or 
other gadgets to 3 hours per day (PC +4.9). Clinical man-
ifestations of LD in a patient increased the risk of possi-
ble insulin-resistant (PC +2.6), as did the presence of the 
lactase C/C 13910 gene genotype (PC +5.8). The presence 
of the genotype C/T 13910 has a protective effect on the 
risk of obesity (PC −2.9). However, the lowest risk of in-
sulin-resistant obesity was observed in children with the 
genotype T/T 13910 (PC −12).
The ranking according to the Kullback’s (I) informative 
coefficient showed that the first places among the factors 
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that predict insulin-resistant obesity in children at an 
early diagnostic stage are occupied by the genotype of the 
lactase gene (I = 3.49), the level of basal insulinemia (I = 
3.02) and the lack of daily use up to 2–3 portions of fresh 
vegetables and fruits (I = 2.71), these factors and others 
have a high informative significance (3.0 > I ≥ 1.0). 
A moderate informative (diagnostic) significance (1.0 > 
I ≥ 0.50) was characteristic of the pathological course of 
pregnancy in the proband mother. Low prognostic infor-
mation (0.5 > I ≥ 0.20) is established for the presence of 
chickenpox in history, the prevalence of fast food in the 
diet. These factors have been removed from the prognostic 
model, table 1.
Tab. 1 Prediction table for insulin-resistant obesity in children at an 
early diagnostic stage before the onset of insulin resistance.
Prognostic sign Gradation of the sign PC I
Lactase gene genotype
Т/Т 13910 −12.0
3.49С/Т 13910 −2.9
С/С 13910 −15.8
The level of basal 
insulinemia, mklU/ml
0.88–18.35 −0.8
3.02
≥18.36 −19.0
Daily consumption  
of up to 2–3 portions  
of fresh vegetables  
and fruits
No −17.6
2.71Yes −5.5
The presence  
of pneumonia  
in history
No −5.2
2.51Yes −17.0
Duration of non-
academic time spent  
at a computer/TV
< 1 hour −6.1
2.421–2 houres −10.1
> 3 houres −14.9
Average meal duration
up to 10 minutes −14.5
2.3310–20 minutes −10.6
more than 20 minutes −6.9
Presence of acne 
vulgaris
No −4.8
2.19
Yes −16.0
Daily consumption  
of red meat, sausages, 
potatoes, rice, 
margarine, sugary 
drinks
No −1.1
1.74Yes −16.4
Violation of the age 
norms of puberty 
initiation
No −3.2
1.64Yes −15.8
The age of the child  
at the time  
of inspection
4–8 years −4.5
1.518–12 years −5.2
12–17 years −12.7
Hereditary burden  
of metabolic syndrome
No −12.4
1.16
Yes −12.9
The level of physical 
development  
of the child  
in percentiles
<33.67 −8.0
1.0533.67–67.34 −1.2
>67.34 −11.8
Being overweight  
at an early age
No −3.4
1.01
Yes −13.0
Pathological course  
of pregnancy
No −2.8
0.96
Yes −13.6
Thus, we identified 14 the most prognostically and di-
agnostically significant clinical and biological predictors 
of the formation of insulin-resistant obesity in children 
from 6 to 18 years old, with sufficient informative prognos-
tic significance (I ≥ 0.5), figure 1.
PREDICTORS FORMATION
INSULIN RESISTANCE
Ku
lb
ac
k’
s 
in
fo
rm
at
iv
e 
co
ef
fic
ie
nt
, I
11.  The genotype of the gene lactase 
11.  C/C 13910
12.  The level of basal insulinemia 
11.  more than 18.36 mklU/ml
13.  Lack of daily eating of up to 2−3 portions 
11.  of fresh vegetables and fruits
14.  Postponed pneumonia aged 11−14 years
15.  Non-academic use of gadgets 
11.  for more than 3 hours
16.  Duration of food up to 10 minutes
17.  Presence of acne vulgaris
18.  Daily consumption of red meat, sausages, 
11.  potatoes, rice, margarine, sugary drinks
19.  Violation of puberty initiation
10.  Age from 12 to 17 years
11.  Hereditary burden of metabolic syndrome
12.  The level of physical development 
11.  of more than 67.34 percentiles
13.  Overweight at an early age
14.  Pathological maternal pregnancy
Fig. 1 Predictors of the formation of insulin-resistant obesity in children.
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The developed prognostic model for the development of 
morbid obesity in children has excellent operational char-
acteristics, figure 2.
Sensitivity 94.64%, specificity 84.91% and their gen-
eralized indicator is the area under the ROC curve AUC = 
0.945 (p < 0.001) with 95% CI 0.884–0.980. Test predict 
a negative result −83.16%. The proportion of correct pre-
diction of the patient’s actual belonging to one group or 
another (whether it is insulin-resistant obesity or not) was 
87.16%, which indicates a high consistency in the actual 
distribution of observations for the presence of patho-
logical obesity and distribution based on the prognostic 
model.
DISCUSSION
The presented model for predicting insulin-resistant 
obesity in children confirmed the data of previous stud-
ies on the importance of lifestyle modification: nutrition 
and physical activity (2, 3, 10). Excess lactose in the diet 
of modern humans causes clinical manifestations of ge-
netically determined lactase deficiency (11). A survey con-
ducted by Lucyna Ostrowska et al. (12) showed that the 
ability to digest lactose in adult men correlates with low 
basal hyperinsulinemia. In individuals with the C/C 13910 
genotype, reduction of the signaling pathway Gal-9/Tim-
3 stimulates the synthesis of pro-inflammatory cytokines 
and forms a metabolically unfavorable insulin-resistant 
phenotype.
According to our study, the maximum risk of insu-
lin-resistant was observed at the age from 12 to 17 years. 
The presence of pneumonia, precisely during puberty (13), 
which is characterized by the presence of physiological in-
sulin resistance significantly, worsens the risk of metabol-
ic adverse obesity in children. 
The data obtained coincide with the results of studies 
demonstrating the relationship between inhibition of ex-
cess galectin-9/Tim-3 signaling pathway by excess lactose 
and the level of invasiveness of pathological factors (14). 
Violation of the initiation of sexual development has 
gender dissociation and is associated with the develop-
ment of normogonadotropic hypogonadism in boys and 
the syndrome of isolated adrenarche in girls. At the same 
time, activation of contrinsular hormones explains accel-
erated physical development and high height with insulin 
resistance. Chronic hyperinsulinemia, which is primarily 
compensatory, to support euglycemia, leads to the activa-
tion of lipolysis in visceral adipose tissue with the release 
of free fatty acids (FFA), which is an important metabolic 
risk factor for dyslipoproteinemia and leptin-resistance 
progression. FFA, among which acetate (60%), butyrate 
(15–20%), propionate (20–25%), which also accumulate 
when excessive use of lactose in the intestinal lumen, in-
teract with the receptor GRP41 enteroendocrine cells of 
the intestine, causing an increase in the synthesis of the 
intestinal peptide YY, which slows down the intestinal 
transit time and reduces the feeling of fullness (7).
Despite the progress achieved in endocrinology and 
molecular genetics, the problem of childhood obesity re-
mains highly relevant and requires further research on 
the influence on key metabolic risk factors.
CONCLUSION
The main risk factors for the development of pathological 
obesity in the early diagnostic stage are the genotype of 
0 20 40 60 80 100
100-Specicity
AUC = 0.945
P < 0.001
Sensitivity: 94.6
Specicity: 84.9
Criterion: ≥13.5
0
20
40
60
80
100
Se
ns
iti
vi
ty
Fig. 2 Operational characteristics of a model for predicting morbid obesity in children at an early diagnostic stage according to ROC analysis.
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the lactase C/C 13910 gene, basal hyperinsulinemia and the 
lack of daily consumption of up to 2–3 portions of fresh 
vegetables and fruits.
To increase the effectiveness of planning personalized 
preventive and rehabilitation measures for overweight 
patients, it is proposed that practical doctors use the al-
gorithm we developed for predicting pathological obesity 
in children with different genotypes of the lactase gene 
at an early diagnostic stage. The use of lactase gene gen-
otyping and a HBTLL in all overweight patients is recom-
mended to exclude lactose maldigestion. Children with 
obesity, with the genotype of the C/C 13910 lactase gene 
and a HBTLL index less than 19 pmm, must be prescribed 
low-lactose diet therapy with the calculation of the level of 
lactose tolerance according to the innovative “Low-lactose 
diet” computer program that we have presented (15). In 
children with obesity, with the genotype of the C/C 13910 
lactase gene and lactose maldigestion with a HBTLL index 
of more than 20 pmm, it is necessary to use a combination 
of low-lactose diet therapy and exogenous lactase drug at 
a dose of 3000 ALU three times a day for 1 month (16).
Prevention of insulin-resistant obesity in a child must 
begin from the moment of birth during the preparation 
of a genetic passport, especially when there is the hered-
itary burden of the metabolic syndrome, the pathological 
course of pregnancy in the mother, macrosomia and the 
presence of the C/C 13910 genotype of the whole family.
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